HDFC Life Insurance Company gains on rolling out ‘Cardiac Risk Assessment at Home’

HDFC Life Insurance Co is currently trading at Rs. 562.05, up by 4.05 points or 0.73% from its previous closing of Rs. 558.00 on the BSE.

HDFC Life Insurance
HDFC Life Insurance

The scrip opened at Rs. 560.00 and has touched a high and low of Rs. 563.80 and Rs. 558.85 respectively. So far 23328 shares were traded on the counter.

The BSE group ‘A’ stock of face value Rs. 10 has touched a 52 week high of Rs. 775.65 on 02-Sep-2021 and a 52 week low of Rs. 497.30 on 08-Mar-2022.

Last one week high and low of the scrip stood at Rs. 565.65 and Rs. 546.25 respectively. The current market cap of the company is Rs. 118802.56 crore.

The promoters holding in the company stood at 51.53%, while Institutions and Non-Institutions held 34.12% and 14.35% respectively.

HDFC Life Insurance Company has rolled out ‘Cardiac Risk Assessment at Home’. ‘Cardiac Risk Assessment at Home’ will provide ease to individuals who have to undergo medicals while applying for an HDFC Life insurance policy.

HDFC Life along with Cardiotrack (known as Uber Diagnostic) has developed a unique test for cardiac risk assessment that can be easily conducted in the comfort of one’s home.

Once the medical appointment is booked, an HDFC Life representative will visit the applicant’s home with the equipment that involves a stepper (with speed and resistance adjustments) and Cardiotrack portable ECG equipment.

The representative will connect the prospective policyholder with a physician via a live video call and the readings would be recorded in real time as the test is being conducted.

HDFC Life Insurance Company is one of the leading life insurance companies in India offering a range of individual and group insurance solutions that meet various customer needs such as Protection, Pension, Savings & Investment and Health, along with Children’s and Women’s Plan.

Leave a Comment